Quest Diagnostics (DGX) vs Oscar Health (OSCR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Oscar Health (OSCR) has outperformed Quest Diagnostics (DGX) over the past year, gaining 51.8% versus a gain of 27.6%. Over five years, OSCR leads with a +108.8% price change compared with +62.0% for DGX. Quest Diagnostics is the larger company by market cap ($25.48 billion vs $10.22 billion), about 2.5 times the size, while Oscar Health is growing revenue faster (+27.5% vs +11.8%).
On valuation, Oscar Health trades at a lower forward P/E (15.3x vs 19.2x for Quest Diagnostics). Quest Diagnostics pays a dividend yielding 1.44%, while Oscar Health does not currently pay one. Quest Diagnostics converts more of its revenue into profit, with a net margin of 9.0% versus -3.8%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | DGX | OSCR |
|---|---|---|
| Share price | $230.81 | $33.10 |
| Market cap | $25.48B | $10.22B |
| 1-day change | +1.65% | +0.58% |
| YTD return | +33.01% | +130.34% |
| 1-year return | +27.60% | +51.83% |
| 5-year return | +61.97% | +108.83% |
| P/E ratio (TTM) | 24.50 | 25.66 |
| Forward P/E | 19.18 | 15.29 |
| EPS (TTM) | $9.42 | $1.29 |
| Dividend yield | 1.44% | 0.00% |
| Annual dividend | $3.32 | $0.00 |
| Revenue (latest FY) | $11.04B | $11.70B |
| Revenue growth (YoY) | +11.78% | +27.50% |
| Net income (latest FY) | $992.00M | $-443.15M |
| Gross margin | 33.21% | — |
| Operating margin | 14.10% | -3.39% |
| Net margin | 8.99% | -3.79% |
| 52-week high | $248.84 | $34.48 |
| 52-week low | $171.18 | $10.69 |
| Distance from 52-week high | -7.25% | -4.00% |
| Analyst consensus | buy | hold |
| Avg. price target upside | +7.48% | +6.95% |
| Average volume | 1.04M | 5.20M |
| Shares outstanding | 110.37M | 273.47M |
| Employees | 46,000 | 2,305 |
| Sector | Health Care | Health Care |
| Industry | Medical Specialities | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Quest Diagnostics is about 2.5 times larger than Oscar Health by market value ($25.48B vs $10.22B).
- OSCR has outperformed DGX by 24.2 percentage points over the past year.
- Quest Diagnostics offers a meaningfully higher dividend yield (1.44% vs 0.00%).
- Quest Diagnostics is more profitable, keeping 9.0 cents of every revenue dollar as net income versus -3.8 cents for Oscar Health.
- Oscar Health grew revenue faster in its latest fiscal year (+27.50% vs +11.78%).
About Quest Diagnostics
DGX stock →Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services.
Health Care · Medical Specialities · 46,000 employees
About Oscar Health
OSCR stock →Oscar Health, Inc. operates as a healthcare technology company in the United States.
Health Care · Medical Specialities · 2,305 employees
DGX vs OSCR FAQ
Which is bigger, Quest Diagnostics or Oscar Health?
Quest Diagnostics (DGX) is larger, with a market capitalization of $25.48B compared with $10.22B for Oscar Health (OSCR).
Which stock has performed better over the past year, DGX or OSCR?
OSCR returned +51.83% over the past 12 months, compared with +27.60% for DGX (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, DGX or OSCR?
DGX has the lower trailing P/E at 24.5, versus 25.7 for OSCR. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Quest Diagnostics or Oscar Health?
Quest Diagnostics pays a dividend yielding 1.44%, while Oscar Health does not currently pay a regular dividend.
Are Quest Diagnostics and Oscar Health in the same industry?
Yes. Both are classified in the Medical Specialities industry within the Health Care sector.